Suppr超能文献

妊娠期生物制剂治疗的最新进展。

An Update on Biologic Agents During Pregnancy.

机构信息

Maternal-Fetal Medicine, Intermountain Healthcare, and the University of Utah, 5121 S Cottonwood Street, Ste 100, Murray, UT 84115, USA.

Maternal-Fetal Medicine, Intermountain Healthcare, and the University of Utah, 5121 S Cottonwood Street, Ste 100, Murray, UT 84115, USA.

出版信息

Clin Perinatol. 2020 Dec;47(4):733-742. doi: 10.1016/j.clp.2020.08.003. Epub 2020 Oct 16.

Abstract

Most biological agents are safe to use in pregnancy. Biologic agents may be divided into 4 risk categories: minimal, uncertain, moderate, and high. Treatment options should be individualized to each patient's disease activity, response to medication, and adverse effects. Hydroxychloroquine, sulfasalazine, azathioprine, cyclosporine A, and low-dose aspirin are considered safe. Glucocorticoids may increase the risk of gestational diabetes and gestational hypertension/preeclampsia. Nonsteroidal medication should only be used during the first trimester and for a short period during the second trimester. Limited experience with tumor necrosis factor-α inhibitor medications suggests minimal risk. Methotrexate, mycophenolate, and leflunomide are contraindicated during pregnancy.

摘要

大多数生物制剂在妊娠期间使用是安全的。生物制剂可分为 4 个风险类别:低、不确定、中、高。治疗选择应根据每位患者的疾病活动度、药物反应和不良反应进行个体化。羟氯喹、柳氮磺胺吡啶、硫唑嘌呤、环孢素 A 和低剂量阿司匹林被认为是安全的。糖皮质激素可能增加妊娠期糖尿病和妊娠高血压/子痫前期的风险。非甾体类药物仅应在孕早期和孕中期短时间内使用。肿瘤坏死因子-α抑制剂药物的有限经验表明风险较低。甲氨蝶呤、霉酚酸酯和来氟米特在怀孕期间禁用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验